Skip to main content
. 2020 Sep 15;11:531. doi: 10.3389/fendo.2020.00531

Table 1.

Comparison of clinical and laboratory findings of patient and control groupe.

FS group (n = 55) Fc group (n = 42) Hc group (n = 48) P-value
Age (months) 35.38 ± 21.19 42.52 ± 21.40 41.35 ± 24.50 >0.05*
Sex (male/female)d 32/23 22/20 26/22 >0.05
BT (°C) on admission 39.39 ± 0.65b 39.34 ± 0.57c 36.69 ± 0.27a <0.05*
WBC (×109/L) 6.00 (2.70–21.65) 7.94 (2.10–31.86) 6.29 (3.70–9.54) >0.05#
N (%) 48.06 ± 25.25 42.74 ± 20.18 43.15 ± 14.99 >0.05*
HB (g/L) 119.75 ± 9.54a 124.76 ± 7.86b 125.42 ± 10.19c <0.05*
PLT (×109/L) 200.56 ± 70.95a 256.86 ± 111.47b 251.44 ± 91.16c <0.05*
CRP (mg/L) 2.00 (0.50–90.30) 1.75 (0.50–15.80) 1.65 (0.50–7.10) >0.05#
Glucose (mmol/L) 5.50 (3.48–8.61) 5.33 (4.77–8.64) 5.25 (4.59–8.64) >0.05#
Sodium (mmol/L) 137 (130–142)a 138 (133–149)b 138 (134–149)c <0.05#

FS, febrile seizures; FC, febrile control; HC, healthy control; WBC, white blood cell; HB, hemoglobin; N, neutrophil; PLT, platelet; CRP, C-reactive protein.

#

The P-value is for Kruskal-Wallis test;

*

The P-value is for One-way ANOVA test.

a, b, c

on means refer to significant difference between means when K-W or One-way ANOVA test refers to significance by multiple comparison analysis (bc, non-significant; ab, ac, significant).

d

Chi-square test.

e

Data shown mean ± standard deviation and median (min–max).